Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic Proteomic and Pharmacogenomic Correlative Study
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
No Description Available
Description
No Description Available
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast
-
Age: Between 18 Years - 100 Years
-
Gender: Female
Updated on
23 Apr 2024.
Study ID: 1011003573 (0407-08)